About all

Vitamin d2 50 000 iu side effects. Vitamin D2 50,000 IU Side Effects: Comprehensive Analysis of Common, Severe, and Long-Term Impacts

by alexxlab

What are the potential side effects of taking 50,000 IU of Vitamin D2. How do common, severe, and long-term effects differ. Are there specific risks associated with high-dose Vitamin D supplementation. What factors influence the safety and efficacy of Vitamin D2 supplementation.

Understanding Vitamin D2 and Its Role in Health

Vitamin D2, also known as ergocalciferol, is a crucial nutrient that plays a vital role in maintaining overall health. It is one of the two major forms of vitamin D, the other being vitamin D3 (cholecalciferol). While both forms are important for human health, they differ in their sources and effectiveness.

Vitamin D2 is primarily derived from plant sources and is often used in fortified foods and supplements. Its primary function is to help the body absorb calcium and phosphorus, essential minerals for bone health. However, the benefits of vitamin D extend far beyond skeletal health.

Key Functions of Vitamin D2

  • Promotes calcium absorption in the gut
  • Maintains adequate serum calcium and phosphate concentrations
  • Supports bone growth and remodeling
  • Modulates cell growth and immune function
  • Reduces inflammation

Despite its importance, vitamin D deficiency is a global health concern. Factors such as limited sun exposure, dark skin pigmentation, and certain medical conditions can contribute to low vitamin D levels. To address this issue, high-dose vitamin D supplementation, such as 50,000 IU of vitamin D2, is sometimes prescribed.

The Science Behind 50,000 IU Vitamin D2 Supplementation

High-dose vitamin D2 supplementation, typically 50,000 IU, is often prescribed to rapidly correct vitamin D deficiency or maintain adequate levels in individuals at high risk of deficiency. This approach has been the subject of numerous studies, with researchers investigating its efficacy and potential side effects.

Do high doses of vitamin D2 effectively raise serum 25-hydroxyvitamin D levels? Studies have shown that large, single doses of vitamin D2 can significantly increase vitamin D levels in the blood. However, the effectiveness may vary among individuals due to factors such as body weight, baseline vitamin D status, and genetic variations in vitamin D metabolism.

Comparing Vitamin D2 and D3 Supplementation

While both vitamin D2 and D3 can be effective in raising serum 25-hydroxyvitamin D levels, research suggests that vitamin D3 may be more potent and longer-lasting. A study by Armas et al. (2004) found that vitamin D3 was approximately 87% more potent in raising and maintaining serum 25-hydroxyvitamin D concentrations compared to vitamin D2.

Is vitamin D2 supplementation as effective as vitamin D3 for all health outcomes? The answer is not straightforward. While both forms can improve vitamin D status, some studies suggest that vitamin D3 may be superior in reducing the risk of fractures and overall mortality. However, more research is needed to fully understand the comparative effects of these two forms on various health outcomes.

Common Side Effects of 50,000 IU Vitamin D2

While vitamin D2 supplementation is generally considered safe, high doses can lead to various side effects. It’s important to note that the occurrence and severity of these side effects can vary among individuals.

Gastrointestinal Disturbances

One of the most commonly reported side effects of high-dose vitamin D2 supplementation is gastrointestinal discomfort. This may include:

  • Nausea
  • Vomiting
  • Constipation
  • Abdominal pain
  • Diarrhea

These symptoms are typically mild and transient, often resolving on their own or with a reduction in dosage. However, persistent or severe gastrointestinal symptoms should be reported to a healthcare provider.

Headaches and Fatigue

Some individuals may experience headaches or increased fatigue after taking high doses of vitamin D2. These symptoms are usually temporary and may subside as the body adjusts to the supplementation.

Can headaches and fatigue be mitigated while taking high-dose vitamin D2? Staying well-hydrated and ensuring adequate intake of other essential nutrients, particularly magnesium, may help alleviate these symptoms. However, if symptoms persist or worsen, it’s crucial to consult with a healthcare professional.

Severe Side Effects and Risks of High-Dose Vitamin D2

While rare, high-dose vitamin D2 supplementation can lead to more serious side effects, particularly if taken for extended periods or in combination with certain medical conditions or medications.

Hypercalcemia

One of the most significant risks associated with excessive vitamin D intake is hypercalcemia, a condition characterized by abnormally high levels of calcium in the blood. Symptoms of hypercalcemia may include:

  • Confusion
  • Weakness
  • Kidney problems
  • Bone pain
  • Cardiac arrhythmias

What level of vitamin D supplementation can lead to hypercalcemia? While the risk of hypercalcemia from vitamin D2 supplementation alone is low at recommended doses, individuals with certain conditions (such as primary hyperparathyroidism or granulomatous disorders) may be more susceptible. Regular monitoring of serum calcium levels is essential for those on high-dose vitamin D therapy.

Kidney Stones

High levels of vitamin D can increase calcium absorption, potentially leading to an increased risk of kidney stone formation in susceptible individuals. This risk is particularly relevant when high-dose vitamin D supplementation is combined with calcium supplements.

How can the risk of kidney stones be minimized while taking high-dose vitamin D2? Maintaining adequate hydration and avoiding excessive calcium intake can help reduce the risk of kidney stone formation. Additionally, individuals with a history of kidney stones should consult their healthcare provider before starting high-dose vitamin D supplementation.

Long-Term Effects of 50,000 IU Vitamin D2 Supplementation

While short-term use of high-dose vitamin D2 is generally considered safe under medical supervision, the long-term effects of sustained high-dose supplementation are less well understood.

Potential Benefits

Long-term vitamin D supplementation may offer several potential health benefits, including:

  • Improved bone health and reduced fracture risk
  • Enhanced immune function
  • Potential reduction in risk of certain cancers
  • Possible cardiovascular benefits

However, it’s important to note that many of these potential benefits are still under investigation, and more research is needed to establish definitive long-term effects.

Potential Risks

Prolonged use of high-dose vitamin D2 may also carry some risks:

  • Increased risk of hypercalcemia and its associated complications
  • Potential for vitamin D toxicity
  • Possible increased risk of falls in older adults (associated with very high doses)

Does long-term high-dose vitamin D2 supplementation increase the risk of adverse health outcomes? While some studies have suggested potential risks associated with long-term high-dose vitamin D supplementation, the evidence is mixed. A 2019 meta-analysis published in JAMA found no significant association between vitamin D supplementation and reduced risk of major adverse cardiovascular events or all-cause mortality. However, the study also noted that further research is needed to evaluate the effects of vitamin D supplementation on other health outcomes.

Factors Influencing Vitamin D2 Side Effects

The occurrence and severity of side effects from 50,000 IU vitamin D2 supplementation can be influenced by various factors. Understanding these factors can help in minimizing risks and optimizing the benefits of supplementation.

Individual Variability

Several individual factors can affect how a person responds to high-dose vitamin D2:

  • Age
  • Body weight
  • Baseline vitamin D status
  • Genetic variations in vitamin D metabolism
  • Presence of certain medical conditions

How do these factors impact the risk of side effects? For example, older adults and individuals with obesity may require higher doses of vitamin D to achieve optimal serum levels, potentially increasing their risk of side effects. Conversely, individuals with certain genetic variations may be more sensitive to vitamin D supplementation and may experience side effects at lower doses.

Concurrent Medications and Supplements

Certain medications and supplements can interact with vitamin D2, potentially altering its effectiveness or increasing the risk of side effects. These include:

  • Steroids
  • Certain antiseizure medications
  • Cholesterol-lowering statins
  • Calcium supplements
  • Thiazide diuretics

What precautions should be taken when combining high-dose vitamin D2 with other medications? It’s crucial to inform healthcare providers about all medications and supplements being taken before starting high-dose vitamin D2 supplementation. In some cases, dosage adjustments or additional monitoring may be necessary to prevent adverse interactions.

Monitoring and Managing Vitamin D2 Supplementation

Given the potential for side effects and the variability in individual responses to high-dose vitamin D2 supplementation, proper monitoring and management are essential.

Regular Blood Tests

Periodic blood tests to measure serum 25-hydroxyvitamin D levels are crucial for assessing the effectiveness of supplementation and detecting potential toxicity. The optimal frequency of testing may vary based on individual factors and the dosing regimen.

What serum 25-hydroxyvitamin D levels should be targeted? While optimal levels are still debated, most experts agree that levels between 30-50 ng/mL (75-125 nmol/L) are sufficient for most individuals. Levels above 100 ng/mL (250 nmol/L) are generally considered excessive and may increase the risk of adverse effects.

Dosage Adjustment

Based on blood test results and the presence of any side effects, healthcare providers may need to adjust the dosage of vitamin D2 supplementation. This may involve:

  • Reducing the frequency of high-dose supplementation
  • Switching to a lower daily dose
  • Temporarily discontinuing supplementation if levels become too high

How quickly should dosage adjustments be made in response to side effects? While minor side effects may resolve on their own, persistent or severe symptoms should prompt immediate consultation with a healthcare provider. Dosage adjustments should be made under medical supervision to ensure safety and efficacy.

Alternative Approaches to Vitamin D Supplementation

While 50,000 IU vitamin D2 supplementation can be effective in rapidly correcting deficiency, alternative approaches may be more suitable for long-term maintenance of vitamin D levels.

Daily Low-Dose Supplementation

For many individuals, daily low-dose vitamin D supplementation (typically 600-2000 IU per day) may be sufficient to maintain adequate levels. This approach may be associated with a lower risk of side effects compared to high-dose intermittent supplementation.

Is daily low-dose supplementation as effective as high-dose intermittent supplementation? While both approaches can be effective, some studies suggest that daily supplementation may lead to more stable serum vitamin D levels and potentially better overall health outcomes. However, the optimal approach may vary depending on individual factors and specific health goals.

Vitamin D3 vs. D2

As mentioned earlier, vitamin D3 (cholecalciferol) may be more effective than vitamin D2 in raising and maintaining serum vitamin D levels. Consider discussing with a healthcare provider the possibility of switching to vitamin D3 supplementation, particularly for long-term use.

Natural Sources of Vitamin D

While supplementation may be necessary for many individuals, incorporating natural sources of vitamin D into the diet can also be beneficial. These include:

  • Fatty fish (salmon, mackerel, sardines)
  • Egg yolks
  • Mushrooms exposed to UV light
  • Fortified foods (milk, orange juice, cereals)

Additionally, safe sun exposure can help the body produce vitamin D naturally. However, it’s important to balance the benefits of sun exposure with the risks of skin damage and skin cancer.

In conclusion, while 50,000 IU vitamin D2 supplementation can be an effective strategy for correcting vitamin D deficiency, it’s not without potential side effects and risks. Understanding these effects, along with the factors that influence them, can help individuals and healthcare providers make informed decisions about vitamin D supplementation. Regular monitoring, appropriate dosage adjustments, and consideration of alternative approaches are key to maximizing the benefits of vitamin D while minimizing potential risks. As with any supplement regimen, it’s crucial to work closely with a healthcare provider to develop a personalized approach that takes into account individual health status, risk factors, and treatment goals.

LARGE, SINGLE-DOSE, ORAL VITAMIN D SUPPLEMENTATION IN ADULT POPULATIONS: A SYSTEMATIC REVIEW

1. Boonen S, Vanderschueren D, Haentjens P, Lips P. Calcium and vitamin D in the prevention and treatment of osteoporosis – a clinical update. J Intern Med. 2006;259:539–552. [PubMed] [Google Scholar]

2. Fraser DR. Vitamin D. Lancet. 1995;345:104–107. [PubMed] [Google Scholar]

3. Witham MD, Dove FJ, Dryburgh M, Sugden JA, Morris AD, Struthers AD. The effect of different doses of vitamin D(3) on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial. Diabetologia. 2010;53:2112–2119. [PubMed] [Google Scholar]

4. Forman JP, Giovannucci E, Holmes MD, et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension. 2007;49:1063–1069. [PubMed] [Google Scholar]

5. Dobnig H, Pils S, Scharnagl H. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med. 2008;168:1340–1349. [PubMed] [Google Scholar]

6. Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008;117:503–511. [PMC free article] [PubMed] [Google Scholar]

7. Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med. 2008;168:1174–1180. [PMC free article] [PubMed] [Google Scholar]

8. Black PN, Scragg R. Relationship between serum 25-hydroxyvitamin d and pulmonary function in the third national health and nutrition examination survey. Chest. 2005;128:3792–3798. [PubMed] [Google Scholar]

9. Janssens W, Bouillon R, Claes B, et al. Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene. Thorax. 2010;65:215–220. [PubMed] [Google Scholar]

10. Stephenson A, Brotherwood M, Robert R, Atenafu E, Corey M, Tullis E. Cholecalciferol significantly increases 25-hydroxyvitamin D concentrations in adults with cystic fibrosis. Am J Clin Nutr. 2007;85:1307–1311. [PubMed] [Google Scholar]

11. Wolfenden LL, Judd SE, Shah R, Sanyal R, Ziegler TR, Tangpricha V. Vitamin D and bone health in adults with cystic fibrosis. Clin Endocrinol (Oxf) 2008;69:374–381. [PMC free article] [PubMed] [Google Scholar]

12. Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc. 2006;81:353–373. [PubMed] [Google Scholar]

13. Ferrari M, Schenk K, Papadopoulou C, et al. Serum 25-hydroxy vitamin D and exercise capacity in COPD. Thorax. 2011;66:544–545. [PubMed] [Google Scholar]

14. Wilkinson RJ, Llewelyn M, Toossi Z, et al. Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study. Lancet. 2000;355:618–621. [PubMed] [Google Scholar]

15. Laaksi I, Ruohola JP, Tuohimaa P, et al. An association of serum vitamin D concentrations < 40 nmol/L with acute respiratory tract infection in young Finnish men. Am J Clin Nutr. 2007;86:714–717. [PubMed] [Google Scholar]

16. Roth DE, Shah R, Black RE, Baqui AH. Vitamin D status and acute lower respiratory infection in early childhood in Sylhet, Bangladesh. Acta Paediatr. 2010;99:389–393. [PubMed] [Google Scholar]

17. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev. 2001;22:477–501. [PubMed] [Google Scholar]

18. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:1911–1930. [PubMed] [Google Scholar]

19. Ross AC, Manson JE, Abrams SA, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96:53–58. [PMC free article] [PubMed] [Google Scholar]

20. Rosen CJ, Abrams SA, Aloia JF. IOM committee members respond to Endocrine Society vitamin D guideline. J Clin Endocrinol Metab. 2012;97:1146–1152. [PMC free article] [PubMed] [Google Scholar]

21. Unson CG, Litt M, Reisine S, Mahoney-Trella P, Sheperd T, Prestwood K. Adherence to calcium/vitamin D and estrogen protocols among diverse older participants enrolled in a clinical trial. Contemp Clin Trials. 2006;27:215–226. [PubMed] [Google Scholar]

22. Sanfelix-Genovés J, Gil-Guillén VF, Orozco-Beltran D, et al. Determinant factors of osteoporosis patients’ reported therapeutic adherence to calcium and/or vitamin D supplements: a cross-sectional, observational study of postmenopausal women. Drugs Aging. 2009;26:861–869. [PubMed] [Google Scholar]

23. Stephens WP, Klimiuk PS, Berry JL, Mawer EB. Annual high-dose vitamin D prophylaxis in Asian immigrants. Lancet. 1981;2:1199–1202. [PubMed] [Google Scholar]

24. Ish-Shalom S, Segal E, Salganik T, Raz B, Bromberg IL, Vieth R. Comparison of daily, weekly, and monthly vitamin D3 in ethanol dosing protocols for two months in elderly hip fracture patients. J Clin Endocrinol Metab. 2008;93:3430–3435. [PubMed] [Google Scholar]

25. Grossmann RE, Zughaier SM, Liu S, Lyles RH, Tangpricha V. Impact of vitamin D supplementation on markers of inflammation in adults with cystic fibrosis hospitalized for a pulmonary exacerbation. Eur J Clin Nutr. 2012;66:1072–1074. [PMC free article] [PubMed] [Google Scholar]

26. Sanders KM, Stuart AL, Williamson EJ, et al. Annual high-dose vitamin D3 and mental well-being: randomised controlled trial. Br J Psychiatry. 2011;198:357–364. [PubMed] [Google Scholar]

27. Scragg R, Khaw KT, Murphy S. Effect of winter oral vitamin D3 supplementation on cardiovascular risk factors in elderly adults. Eur J Clin Nutr. 1995;49:640–646. [PubMed] [Google Scholar]

28. Grossmann RE, Zughaier SM, Kumari M, et al. Pilot study of vitamin D supplementation in adults with cystic fibrosis pulmonary exacerbation: a randomized, controlled trial. Dermatoendocrinol. 2012;4:191–197. [PMC free article] [PubMed] [Google Scholar]

29. Sanders KM, Stuart AL, Williamson EJ, et al. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA. 2010;303:1815–1822. [PubMed] [Google Scholar]

30. Khaw KT, Scragg R, Murphy S. Single-dose cholecalciferol suppresses the winter increase in parathyroid hormone concentrations in healthy older men and women: a randomized trial. Am J Clin Nutr. 1994;59:1040–1044. [PubMed] [Google Scholar]

31. Romagnoli E, Mascia ML, Cipriani C, et al. Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly. J Clin Endocrinol Metab. 2008;93:3015–3020. [PubMed] [Google Scholar]

32. Rossini M, Alberti V, Flor L, et al. Effect of oral vitamin D2 yearly bolus on hip fracture risk in elderly women: a community primary prevention study. Aging Clin Exp Res. 2004;16:432–436. [PubMed] [Google Scholar]

33. Latham NK, Anderson CS, Lee A, Bennet DA, Moseley A, Cameron ID. A randomized, controlled trial of quadriceps resistance exercise and vitamin D in frail older people: the Frailty Interventions Trial in Elderly Subjects (FITNESS) J Am Geriatr Soc. 2003;51:291–299. [PubMed] [Google Scholar]

34. Rossini M, Gatti D, Viapiana O, et al. Short-term effects on bone turnover markers of a single high dose of oral vitamin D3. J Clin Endocrinol Metab. 2012;97:E622–E626. [PubMed] [Google Scholar]

35. Premaor MO, Scalco R, da Silva MJ, Froelich PE, Furlanetto TW. The effect of a single dose versus a daily dose of cholecalciferol on the serum 25-hydroxycholecalciferol and parathyroid hormone levels in the elderly with secondary hyperparathyroidism living in a low-income housing unit. J Bone Miner Metab. 2008;26:603–608. [PubMed] [Google Scholar]

36. Tellioglu A, Basaran S, Guzel R, Seydaoglu G. Efficacy and safety of high dose intramuscular or oral cholecalciferol in vitamin D deficient/insufficient elderly. Maturitas. 2012;72:332–338. [PubMed] [Google Scholar]

37. von Restorff C, Bischoff-Ferrari HA, Theiler R. High-dose oral vitamin D3 supplementation in rheumatology patients with severe vitamin D3 deficiency. Bone. 2009;45:747–749. [PubMed] [Google Scholar]

38. Sakalli H, Arslan D, Yucel AE. The effect of oral and parenteral vitamin D supplementation in the elderly: a prospective, double-blinded, randomized, placebo-controlled study. Rheumatol Int. 2012;32:2279–2283. [PubMed] [Google Scholar]

39. Bacon CJ, Gamble GD, Horne AM, Scott MA, Reid IR. High-dose oral vitamin D3 supplementation in the elderly. Osteoporos Int. 2009;20:1407–1415. [PubMed] [Google Scholar]

40. Ilahi M, Armas LA, Heaney RP. Pharmacokinetics of a single, large dose of cholecalciferol. Am J Clin Nutr. 2008;87:688–691. [PubMed] [Google Scholar]

41. Leventis P, Kiely PD. The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency. Scand J Rheumatol. 2009;38:149–153. [PubMed] [Google Scholar]

42. Cipriani C, Romagnoli E, Scillitani A, et al. Effect of a single oral dose of 600,000 IU of cholecalciferol on serum calciotropic hormones in young subjects with vitamin D deficiency: a prospective intervention study. J Clin Endocrinol Metab. 2010;95:4771–4777. [PubMed] [Google Scholar]

43. Witham MD, Dove FJ, Sugden JA, Doney AS, Struthers AD. The effect of vitamin D replacement on markers of vascular health in stroke patients – a randomised controlled trial. Nutr Metab Cardiovasc Dis. 2012;22:864–870. [PubMed] [Google Scholar]

44. Sugden JA, Davies JI, Witham MD, Morris AD, Struthers AD. Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels. Diabet Med. 2008;25:320–325. [PubMed] [Google Scholar]

45. Stricker H, Tosi Bianda F, Guidicelli-Nicolosi S, Limoni C, Colucci G. Effect of a single, oral, high-dose vitamin D supplementation on endothelial function in patients with peripheral arterial disease: a randomised controlled pilot study. Eur J Vasc Endovasc Surg. 2012;44:307–312. [PubMed] [Google Scholar]

46. Selimoglu H, Duran C, Kivici S, et al. The effect of vitamin D replacement therapy on insulin resistance and androgen levels in women with polycystic ovary syndrome. J Endocrinol Invest. 2010;33:234–238. [PubMed] [Google Scholar]

47. Lasco A, Catalano A, Benvenga S. Improvement of primary dysmenorrhea caused by a single oral dose of vitamin D: results of a randomized, double-blind, placebo-controlled study. Arch Intern Med. 2012;172:366–367. [PubMed] [Google Scholar]

48. Stoll D, Dudler J, Lamy O, Hans D, Krieg MA, Aubry-Rozier B. Can one or two high doses of oral vitamin D3 correct insufficiency in a non-supplemented rheumatologic population? Osteoporos Int. 2013;24:495–500. [PubMed] [Google Scholar]

49. Malham M, Peter Jørgensen S, Lauridsen AL, Ott P, Glerup H, Dahlerup JF. The effect of a single oral mega-dose of vitamin D provided as either ergocalciferol (D2) or cholecalciferol (D3) in alcoholic liver cirrhosis. Eur J Gastroenterol Hepatol. 2012;24:172–178. [PubMed] [Google Scholar]

50. Martineau AR, Wilkinson RJ, Wilkinson KA, et al. A single dose of vitamin D enhances immunity to mycobacteria. Am J Respir Crit Care Med. 2007;176:208–213. [PubMed] [Google Scholar]

51. Martineau AR, Nanzer AM, Satkunam KR, et al. Influence of a single oral dose of vitamin D(2) on serum 25-hydroxyvitamin D concentrations in tuberculosis patients. Int J Tuberc Lung Dis. 2009;13:119–125. [PubMed] [Google Scholar]

52. Amrein K, Sourij H, Wagner G, et al. Short-term effects of high-dose oral vitamin D3 in critically ill vitamin D deficient patients: a randomized, double-blind, placebo-controlled pilot study. Crit Care. 2011;15:R104. [PMC free article] [PubMed] [Google Scholar]

53. Yu CK, Sykes L, Sethi M, Teoh TG, Robinson S. Vitamin D deficiency and supplementation during pregnancy. Clin Endocrinol (Oxf) 2009;70:685–690. [PubMed] [Google Scholar]

54. Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ. 2003;326:469. [PMC free article] [PubMed] [Google Scholar]

55. Heikinheimo RJ, Inkovaara JA, Harju EJ, et al. Annual injection of vitamin D and fractures of aged bones. Calcif Tissue Int. 1992;51:105–110. [PubMed] [Google Scholar]

56. Maierhofer WJ, Gray RW, Cheung HS, Lemann J., Jr Bone resorption stimulated by elevated serum 1,25-(OH)2-vitamin D concentrations in healthy men. Kidney Int. 1983;24:555–560. [PubMed] [Google Scholar]

57. Yamaguchi M, Weitzmann MN. High dose 1,25(OH)2D3 inhibits osteoblast mineralization in vitro. Int J Mol Med. 2012;29:934–938. [PubMed] [Google Scholar]

5 harmful side effects of vitamin D you need to know about

It’s been a year, since we’ve been hearing about immunity. Vitamin D has always been considered a godsend, and its importance has only grown during this time. The best way to consume this vitamin is by exposing ourselves to the sun, but if we talk realistically, we hardly get any of it. That’s what makes us all dependent on vitamin D supplements, and that’s where the trouble begins.

There’s no denying that vitamin D is critical for our bodies. Basically, it is a fat-soluble vitamin that helps in the better absorption of calcium and phosphorus. So, when it comes to building and strengthening bones, it is a necessity. In addition, it is required to treat bone disorders such as rickets. It keeps the cells healthy and contributes to its proper functioning. 

Unfortunately, most of us knowingly or unknowingly opt for over-the-counter supplement brands without understanding the science behind consuming it. That’s a big reason why we end up bearing its side effects. 

You know why? That’s because when you consume more than the stipulated amount, then it leads to the build-up of toxins in your body.

Here are five side-effects of overdosing on vitamin D supplements according to nutritionist, Ms Manisha Chopra

1. Vomiting, nausea, and loss of appetite

Consuming excess amounts of vitamin D supplements increases calcium levels in the blood, which can cause side-effects like nausea, vomiting and loss of appetite.

We might have been underestimating vitamin D all this while. Image courtesy: Shutterstock

2. Stomach and constipation

Elevated calcium levels also cause digestive problems. Consuming vitamin D supplements in high quantities can cause stomach ache, diarrhea and constipation, due to excessive calcium in the blood.

3. Bone loss

“Vitamin D is essential to maintain bone health, and it plays an important role in the absorption of calcium in the body and bone metabolism. However, too much vitamin D can cause a threat to bone health, as it lowers the vitamin K2 level in the blood, which keeps calcium in the bone and blood. Hence, excessive consumption of vitamin D supplements can cause bone loss. To avoid this, one can include foods rich in vitamin K2 in the diet,” suggests Ms Chopra.

Track your health on the go ! Download Healthshots App

4. Hypercalcemia

It can lead to hypercalcemia, which means calcium levels get elevated in the blood. Excessive intake of vitamin D can increase the calcium level in the blood, and can cause harmful effects like fatigue, dizziness, excessive thirst, frequent urination, etc.

Don’t underestimate the importance of vitamin D but don’t overrule the possibility of its side-effects. Image courtesy: Shutterstock

5. Kidney damage

An overdose of vitamin D can result in kidney injury in people who have healthy kidneys. It is even more harmful for those who suffer from an existing kidney problem.

So ladies, whether you are popping supplements to stay immune from covid-19 or because you are pregnant, just be sure that you don’t take them without proper prescription.

composition, indications, dosage, side effects

Ergocalciferol (Vitamin D2) belongs to the group of vitamin D preparations and its analogues, which plays an important role in the regulation of calcium and phosphorus metabolism in the body. The action of the drug is especially manifested in such a disease as rickets, being distributed and deposited in the bones with their growth.

Composition and formulation

Ergocalciferol (Vitamin D2) is produced in the form of a clear oily solution, which can be from light yellow to dark yellow.

The active ingredient of the drug is ergocalciferol (vitamin D 2).

Auxiliary components in the composition: sunflower oil refined, frozen, deodorized grade “P”.

The drug is packed in a cardboard box, 1 vial (10 ml).

Indications

Ergocalciferol (Vitamin D2) is used to treat and prevent hypovitaminosis D and rickets.

Also, the drug is indicated for calcium metabolism disorders that caused bone diseases (osteoporosis of various forms, osteomalacia), for bone and skin tuberculosis, tetany (impaired functional activity of the parathyroid glands), systemic lupus erythematosus, psoriasis.

Contraindications

Contraindications for the use of Ergocalciferol (Vitamin D2) are:

• hypersensitivity to the components of the drug;

• active pulmonary tuberculosis;

• hypervitaminosis D;

• peptic ulcer of the stomach and duodenum;

• organic vascular and heart diseases in the stage of decompensation;

• chronic and acute diseases of the kidneys and liver;

• sarcoidosis;

• elevated levels of phosphorus and calcium in urine and blood;

• urolithiasis.

Use during pregnancy and lactation

Ergocalciferol (Vitamin D2) can be used in pregnant women only from 30 or 32 weeks of pregnancy, since long-term use of vitamin D 2 can cause hypercalcemia in the mother and lead to increased sensitivity to the vitamin D, mental retardation, elf-like appearance syndrome, parathyroid suppression, and fetal aortic stenosis.

Women over 35 years of age should use the drug with extreme caution during pregnancy. Care is also needed in the use during breastfeeding, so as not to cause an overdose in the child.

Dosage and Administration

Ergocalciferol (Vitamin D2) is taken orally with meals.

1 ml (approximately 30 drops) contains 50,000 IU.

The solution is applied in drops with an eye dropper, one drop contains 1400 IU.

For rickets, the drug is prescribed at a dose of 1400-5600 IU (depending on the severity of the disease and the clinical picture) per day. The duration of treatment is from 30 to 40 days. After achieving a positive therapeutic effect, it is necessary to prescribe a drug for prevention at a dose of 500 IU per day, until the child is 3 years old. A break in taking the drug is done for the period of the summer months.

For the prevention of rickets in newborns and infants, the drug is prescribed to pregnant women and nursing mothers. During pregnancy, 1400 IU per day is prescribed, starting from 30-32 weeks. The duration of therapy is 6-8 weeks. During lactation, Ergocalciferol is taken from the first days of feeding at a dosage of 500-1000 IU, until the drug can be prescribed to the child himself.

If the child was born full-term, it is possible to prescribe the drug to him from the 3rd week of life. Premature babies, twins, children who are artificially fed or in adverse environmental (including domestic) conditions – from 2 weeks of age.

For premature infants, the prophylactic dose of vitamin D may be 1000 IU each day for the first 6 months of life. In the future, the daily dose is 1400-2800 IU for a month. Treatment is carried out 2-3 times a year, between courses there is a break of 3-4 months.

In pathological processes of bone tissue, rickets-like diseases, which are caused by a violation of calcium metabolism in the body, as well as in psoriasis and some forms of tuberculosis, the drug is used in accordance with the schemes of complex therapy for these diseases.

For the treatment of lupus erythematosus, the drug is prescribed at a dose of 100,000 IU per day – for adult patients and 25,000-75,000 IU per day after meals – for children under 16 years of age, while dividing the daily dose into 2 doses. The duration of therapy is about 6 months.

Overdose

Overdose of Ergocalciferol (Vitamin D2) may cause: diarrhea or constipation, dry mouth, headache, pollakiuria, thirst, nocturia, anorexia, polyuria, metallic taste in the mouth, vomiting, nausea, fatigue , hypercalcemia, asthenia, hypercalciuria.

Later symptoms of hypervitaminosis D are also possible: bone pain, cloudy urine, increased blood pressure, eye photosensitivity, itching, hyperemia, arrhythmia, conjunctiva, drowsiness, nausea, myalgia, vomiting, gastralgia, pancreatitis, weight loss. In rare cases, changes in mood and psyche (including psychosis).

Chronic vitamin D poisoning can cause: calcification of soft tissues, lungs, kidneys and blood vessels, cardiovascular and renal failure (up to death), arterial hypertension, impaired growth of children.

Treatment should be to stop the drug, limit the intake of vitamin D 2 with food, make a gastric lavage or induce vomiting. After that, you need to take activated charcoal and saline laxatives.

Side effects

The use of Ergocalciferol (Vitamin D2) may cause the following side effects: hypersensitivity reactions (including rash, itching, urticaria), headache, sleep disturbance, depression, hyperphosphatemia, vertigo, irritation, increased urinary calcium levels (can lead to manifestations of calcification of internal organs).

May also occur: anorexia, diarrhea, loss of appetite, nausea, rash and itching, vomiting, bone pain, cylindruria, proteinuria, leukocyturia and general weakness.

If any of the above effects appear during treatment, you should stop taking the drug and limit the intake of calcium into the body as much as possible, including with food.

Side effects usually occur when the drug is used in high doses or with long-term use.

Storage conditions and terms

Ergocalciferol (Vitamin D2) should be stored in a refrigerator at a temperature of + 2°C to + 8°C, out of sight of children and in original packaging.

The shelf life of this medicine is 24 months.

Pharmacies are dispensed by prescription.

Ergocalciferol (vitamin D2): instruction, price, analogues | oral oil solution Technolog

  • Pharmacological properties
  • Indications Ergocalciferol
  • Application of Ergocalciferol
  • Contraindications
  • Side effects
  • Special instructions
  • Interactions
  • Overdose
  • Storage conditions
  • Diagnosis
  • Recommended alternatives
  • Trade names

ergocalciferol (24-methyl-9,10-secacholest-5,7,10(19),22-tetraen-3b-ol) is a fat-soluble vitamin D2 preparation. Regulates the exchange of phosphorus and calcium, promotes their absorption in the intestines, distribution in the body, deposition in the bones during their growth. The specific effect of the vitamin is especially evident in rickets.

prevention and treatment of rickets, as well as bone diseases caused by calcium metabolism disorders (various forms of osteoporosis, osteomalacia), dysfunction of the parathyroid glands (tetany), some forms of tuberculosis, psoriasis, lupus lesions of the skin and mucous membranes.

inside. In the treatment of rickets of the 1st degree in full-term children, the daily dose is 10,000–15,000 IU. For a course of treatment (30-45 days) – 500,000-600,000 IU. In the acute course of the disease, the indicated course dose is prescribed for 10 days. The course dose for rickets of the 2nd degree is 600,000–800,000 IU. The course of treatment for this form of the disease is 30–35 days (subacute course) or 10–15 days (acute course). With rickets of the 2nd-3rd degree, repeated anti-relapse treatment is carried out at a course dose of 400,000 IU, which is prescribed for 10 days. For the treatment of grade 3 rickets, the course dose is 800,000–1,000,000 IU. The course of treatment for this form of the disease is 40–60 days (subacute course) or 10–15 days (acute course). Treatment of patients with severe acute rickets (including those with concomitant pneumonia) is carried out only in a hospital, prescribing a dose of 800,000 IU for 3-6 days.

For the prevention of rickets in newborns and infants, ergocalciferol is prescribed to pregnant women and women during lactation. During pregnancy (30–32 weeks), the drug is prescribed in low doses for 10 days (total dose – 400,000–600,000 IU). During lactation, it is prescribed from the first days of feeding at an initial dose of 500 IU / day. For prophylactic purposes, full-term children are prescribed the drug from the 3rd week of life (for a course of about 300,000 IU). Starting from the 2nd week of life, a total dose of 600,000 IU is prescribed for premature babies and artificially fed children, twins, children living in unfavorable environmental, climatic and living conditions. In the prevention of rickets, ergocalciferol is prescribed according to one of the following schemes: “fractional” method – 500-1000 IU daily for 1 year of life; the method of “vitamin pushes” – 50,000 IU once a week for 8 weeks; “compacted” method – premature and children with frequent intercurrent diseases are prescribed 300,000-400,000 IU of the drug for 10-12 days. After treatment with the drug for a year, ergocalciferol is prescribed to a child until the age of 2 years in the autumn-winter period. In regions with a long winter, prophylaxis is continued until the age of 3 years.

The use of the drug in some forms of tuberculosis, psoriasis is carried out in accordance with complex treatment regimens for these diseases.

The daily dose for the prevention of tetany is 1,000,000 IU. With lupus erythematosus in adults – 100,000 IU, children under the age of 16 – after meals at a dose of 25,000-75,000 IU / day in 2 doses. The course of treatment is 5–6 months.

peptic ulcer of the stomach or duodenum, other diseases of the digestive tract, acute and chronic diseases of the liver, kidneys, organic heart disease, active forms of tuberculosis, hypercalcemia.